Oral agents in managing diabetes mellitus in children and adolescents.
Type 2 diabetes mellitus is a chronic disease with potentially devastating long-term complications. Despite the tremendous body of research and experience in the adult population, relatively little is established regarding this condition and its optimal management in children and adolescents. The pediatric community awaits results of ongoing trials as well as further study of optimal intervention in children, as they continue to extrapolate management practices from their adult counterparts.
Jacobson-Dickman
Elka
E
Department of Pediatrics, Massachusetts General Hospital for Children and Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Levitsky
Lynne
L
D000284:Administration, Oral; D000293:Adolescent; D002219:Carbamates / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use; D016896:Treatment Outcome
D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; D013453:Sulfonylurea Compounds; D045162:Thiazolidinediones; C072379:repaglinide; D008687:Metformin; C089946:2,4-thiazolidinedione